Andon Health Co., Ltd. (SHE: 002432)
China
· Delayed Price · Currency is CNY 44.49
-0.51 (-1.13%)
Nov 15, 2024, 3:04 PM CST
Andon Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,519 | 3,172 | 26,265 | 2,340 | 1,996 | 673.12 | Upgrade
|
| Other Revenue | 58.66 | 58.66 | 50.51 | 57.06 | 11.9 | 33.15 | Upgrade
|
| Revenue | 2,578 | 3,231 | 26,315 | 2,397 | 2,008 | 706.28 | Upgrade
|
| Revenue Growth (YoY) | -42.34% | -87.72% | 997.80% | 19.36% | 184.36% | 25.25% | Upgrade
|
| Cost of Revenue | 962.02 | 1,275 | 5,529 | 884.82 | 906.6 | 532.49 | Upgrade
|
| Gross Profit | 1,616 | 1,956 | 20,786 | 1,512 | 1,102 | 173.79 | Upgrade
|
| Selling, General & Admin | 817.85 | 886.05 | 2,004 | 496.55 | 592.82 | 277.66 | Upgrade
|
| Research & Development | 248.23 | 278.46 | 264.89 | 66.73 | 76.54 | 80.03 | Upgrade
|
| Other Operating Expenses | 2.9 | 41.6 | 4.15 | 6.25 | 7.34 | 8.36 | Upgrade
|
| Operating Expenses | 1,063 | 1,203 | 2,286 | 592.96 | 686.29 | 374.29 | Upgrade
|
| Operating Income | 553.26 | 752.66 | 18,500 | 919.31 | 415.47 | -200.51 | Upgrade
|
| Interest Expense | -46.11 | -12.43 | -4.75 | -13.3 | -6.95 | -8.26 | Upgrade
|
| Interest & Investment Income | 852.68 | 735.36 | 274.1 | 62.35 | 327.17 | 11.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 40.13 | 40.13 | 35.26 | -2.2 | -18.8 | -0.15 | Upgrade
|
| Other Non Operating Income (Expenses) | -42.81 | -2.8 | -1.98 | -3.86 | -2.65 | -7.08 | Upgrade
|
| EBT Excluding Unusual Items | 1,357 | 1,513 | 18,803 | 962.29 | 714.23 | -204.96 | Upgrade
|
| Impairment of Goodwill | -89.5 | -89.5 | -125.26 | - | -123.43 | -75.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | 918.41 | 309.29 | -326.4 | 30.49 | -336.92 | 305.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.01 | -0.5 | -6.43 | 0.01 | -0.03 | -0.98 | Upgrade
|
| Asset Writedown | 45.54 | -153.14 | -46.95 | -1.88 | -24.29 | -11.16 | Upgrade
|
| Other Unusual Items | 1.28 | 1.28 | -39.85 | 8.72 | 10.19 | 4.73 | Upgrade
|
| Pretax Income | 2,234 | 1,580 | 18,258 | 999.63 | 239.75 | 18.38 | Upgrade
|
| Income Tax Expense | 334.27 | 231.11 | 1,774 | 65.23 | 2.92 | -8.68 | Upgrade
|
| Earnings From Continuing Operations | 1,900 | 1,349 | 16,484 | 934.4 | 236.83 | 27.06 | Upgrade
|
| Minority Interest in Earnings | -176.11 | -97.62 | -453.93 | -25.76 | 5.5 | 39.39 | Upgrade
|
| Net Income | 1,724 | 1,252 | 16,030 | 908.64 | 242.33 | 66.45 | Upgrade
|
| Net Income to Common | 1,724 | 1,252 | 16,030 | 908.64 | 242.33 | 66.45 | Upgrade
|
| Net Income Growth | 96.61% | -92.19% | 1664.19% | 274.96% | 264.68% | 423.77% | Upgrade
|
| Shares Outstanding (Basic) | 414 | 445 | 456 | 455 | 433 | 443 | Upgrade
|
| Shares Outstanding (Diluted) | 418 | 452 | 467 | 455 | 433 | 443 | Upgrade
|
| Shares Change (YoY) | -12.09% | -3.23% | 2.82% | 5.02% | -2.30% | 4.75% | Upgrade
|
| EPS (Basic) | 4.17 | 2.81 | 35.14 | 2.00 | 0.56 | 0.15 | Upgrade
|
| EPS (Diluted) | 4.12 | 2.77 | 34.30 | 2.00 | 0.56 | 0.15 | Upgrade
|
| EPS Growth | 123.66% | -91.93% | 1615.80% | 257.03% | 273.27% | 400.00% | Upgrade
|
| Free Cash Flow | 662.76 | 1,557 | 18,010 | 222.67 | 407.85 | -104.44 | Upgrade
|
| Free Cash Flow Per Share | 1.59 | 3.44 | 38.53 | 0.49 | 0.94 | -0.24 | Upgrade
|
| Dividend Per Share | 0.300 | 0.300 | 2.500 | 0.700 | 0.060 | - | Upgrade
|
| Dividend Growth | -88.00% | -88.00% | 257.14% | 1066.67% | - | - | Upgrade
|
| Gross Margin | 62.69% | 60.54% | 78.99% | 63.09% | 54.86% | 24.61% | Upgrade
|
| Operating Margin | 21.46% | 23.29% | 70.30% | 38.35% | 20.69% | -28.39% | Upgrade
|
| Profit Margin | 66.85% | 38.74% | 60.92% | 37.91% | 12.07% | 9.41% | Upgrade
|
| Free Cash Flow Margin | 25.71% | 48.20% | 68.44% | 9.29% | 20.31% | -14.79% | Upgrade
|
| EBITDA | 561.36 | 789.08 | 18,574 | 985.28 | 478.25 | -140.98 | Upgrade
|
| EBITDA Margin | 21.77% | 24.42% | 70.58% | 41.10% | 23.81% | -19.96% | Upgrade
|
| D&A For EBITDA | 8.1 | 36.42 | 74.18 | 65.97 | 62.78 | 59.52 | Upgrade
|
| EBIT | 553.26 | 752.66 | 18,500 | 919.31 | 415.47 | -200.51 | Upgrade
|
| EBIT Margin | 21.46% | 23.29% | 70.30% | 38.35% | 20.69% | -28.39% | Upgrade
|
| Effective Tax Rate | 14.96% | 14.62% | 9.71% | 6.53% | 1.22% | - | Upgrade
|
| Revenue as Reported | 2,578 | 3,231 | 26,315 | 2,397 | 2,008 | 706.28 | Upgrade
|
| Advertising Expenses | - | 82.77 | 70.38 | 51.22 | 84.16 | 17.48 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.